Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism

NCT00493961 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Kallmann Syndrome
Idiopathic Hypogonadotropic Hypogonadism
GnRH Deficiency

Interventions

DRUG: gonadotropin releasing hormone (GnRH)

Sponsor

Massachusetts General Hospital